COMMUNIQUÉS West-GlobeNewswire

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
20/05/2026
MALVERN, Pa., May 20, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
Emergent BioSolutions to Participate in Upcoming Investor Conferences
20/05/2026
GAITHERSBURG, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences: [...]
Glass House Brands to Host Investor Sesh V on Thursday, June 18, 2026
20/05/2026
Company to Hold its Fifth Annual ‘Investor Sesh’ in Appreciation of Investor Support and in Commitment to Transparency for Shareholders LONG BEACH, Calif. and TORONTO, May 20, 2026 (GLOBE NEWSWIRE) -- Glass House Brands [...]
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive [...]
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026
20/05/2026
IMVT-1402 showed clinically meaningful response rates of 72.7% ACR20, 54.5% ACR50 and 35.8% ACR70 at Week 16 in the open label period of its trial in difficult-to-treat rheumatoid arthritis (D2T RA); Immunovant will [...]
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
20/05/2026
MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) today announced the commencement of its first clinical trial for an antiparasitic drug candidate powered by Gelteq ® technology, marking a [...]
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
20/05/2026
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2025 Corporate [...]
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform
20/05/2026
ANN ARBOR, Mich., May 20, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced additional [...]
Un essai clinique canadien sans précédent évalue des « comprimés de selles » pour améliorer l’immunothérapie du cancer du poumon
20/05/2026
Financée par la Société canadienne du cancer et la Fondation de la famille Weston, l’étude de recherche LUNA-2 sur les capsules de microbiome sera la plus vaste du genre au Canada LONDON, Ontario, 20 mai 2026 (GLOBE [...]
Avricore Health Announces $1.25 Million Financing
20/05/2026
VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price [...]
Largest-ever Canadian clinical trial tests “poop pills” to improve immunotherapy for lung cancer
20/05/2026
Backed by the Canadian Cancer Society and Weston Family Foundation, the LUNA-2 microbiome capsule research study will be the largest of its kind in Canada LONDON, Ontario, May 20, 2026 (GLOBE NEWSWIRE) -- For nearly [...]
Winner Medical Breaks Ground on New Production Base in Vietnam to Serve Global Medical Supply Chains Through Local Manufacturing
20/05/2026
SHENZHEN, China, May 20, 2026 (GLOBE NEWSWIRE) -- Winner Medical has officially broken ground on its new manufacturing base in Hai Ha Industrial Park, Quang Ha Commune, Quang Ninh Province, Vietnam. With a total [...]
Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
20/05/2026
Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); submission expected to be completed in [...]
CorVel Announces Revenues and Earnings
20/05/2026
FORT WORTH, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $ [...]
Disclosure of voting rights at AGM in Vistin Pharma ASA
20/05/2026
Oslo, Norway, 20 May 2026 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 20th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total [...]
Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders
20/05/2026
Urges Stockholders to Vote “ FOR ” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company [...]
SERB Pharmaceuticals acquiert auprès de Hansa Biopharma les droits européens et MENA d’Idefirix® (imlifidase) pour 115 millions d’euros
20/05/2026
BRUXELLES, 20 mai 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, ci-après « SERB », et Hansa Biopharma AB, ci-après « Hansa » (Nasdaq Stockholm : HNSA) annoncent la conclusion d’un accord portant sur l’acquisition, par [...]
IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions
20/05/2026
Louvain-la-Neuve, Belgium, May 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, [...]
Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder
20/05/2026
Collaboration underway with Prof. Allan Young and King’s College, London First time a Selective Endocannabinoid Reuptake Inhibitor (SERI) molecule is dosed in a patient population BASEL, Switzerland, May 20, 2026 (GLOBE [...]

Pages